BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/13/2020 3:40:10 AM | Browse: 671 | Download: 1862
 |
Received |
|
2020-07-18 06:54 |
|
Peer-Review Started |
|
2020-07-18 06:55 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-08-09 14:36 |
|
Revised |
|
2020-08-22 12:11 |
|
Second Decision |
|
2020-10-15 09:29 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-10-15 16:23 |
|
Articles in Press |
|
2020-10-15 16:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-11-09 02:24 |
|
Publish the Manuscript Online |
|
2020-11-13 03:40 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Li Zhang, Shuai Xue, Jie Hou, Guang Chen and Zhong-Gao Xu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zhong-Gao Xu, MD, PhD, Director, Director, Full Professor, Department of Nephrology, The First Hospital of Jilin University, No.1 Xinmin Street, Changchun 130021, Jilin Province, China. nephrology_jdyy@hotmail.com |
| Key Words |
Endothelin receptor; Endothelin receptor antagonists; Endothelin receptor blockade; Diabetic nephropathy; Meta-analysis; Systematic review |
| Core Tip |
Patients with type 2 diabetes are at increased risk for vascular complications, such as nephropathy, coronary artery disease, and retinopathy. Endothelin receptor (ER) antagonists might be a novel and beneficial drug for diabetic nephropathy (DN). However, no consistent conclusions regarding their effectiveness and safety for patients with DN have been presented. We conducted this meta-analysis of available clinical data on ER antagonists aimed to assess the effectiveness and safety of ER antagonists among patients with DN. |
| Publish Date |
2020-11-13 03:40 |
| Citation |
Zhang L, Xue S, Hou J, Chen G, Xu ZG. Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review. World J Diabetes 2020; 11(11): 553-566 |
| URL |
https://www.wjgnet.com/1948-9358/full/v11/i11/553.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v11.i11.553 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
